Bridgewater Associates’s St Jude Medical STJ Stock Holding History

Bridgewater Associates’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-114,830	Closed	-$6.32M	–	390
2016 Q1	$6.32M	Buy	114,830 +37,663	+49%	+$2.05M	0.08%	100
2015 Q4	$4.77M	Buy	77,167 +21,951	+40%	+$1.38M	0.06%	123
2015 Q3	$3.48M	Buy	+55,216	New	+$3.94M	0.05%	167
2015 Q1	–	Sell	-64,136	Closed	-$4.17M	–	416
2014 Q4	$4.17M	Sell	64,136 -6,100	-9%	-$393K	0.03%	127
2014 Q3	$4.22M	Buy	+70,236	New	+$4.59M	0.03%	115
2013 Q3	–	Sell	-105,185	Closed	-$4.8M	–	428
2013 Q2	$4.8M	Buy	+105,185	New	+$4.56M	0.04%	88

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bridgewater Associates's STJ Position: Q2 2016 in Review

Bridgewater Associates sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 114,830 shares — an estimated $6.32M sold.

Bridgewater Associates first reported a position in STJ in Q2 2013 and held it in 6 quarters. The position peaked at $6.32M in Q1 2016. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

Bridgewater Associates reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
Bridgewater Associates sold 114,830 St Jude Medical shares in Q2 2016, an estimated $6.32M.
Bridgewater Associates first reported a position in St Jude Medical in Q2 2013 and held it in 6 quarters.
Bridgewater Associates's St Jude Medical position peaked at $6.32M in Q1 2016.
615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Bridgewater Associates's 13F filing for Q2 2016, filed 10 Aug 2016.